by Jordana Choucair | Oct 7, 2022 | Life Sciences
U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra said the agency would “continue to explore every option we have” with regard to lowering drug prices. According to Becerra, even utilizing so-called march-in rights — power granted...
by Jordana Choucair | Oct 7, 2022 | Life Sciences
Center for Medicare Director Meena Seshamani said drugmakers who raise prices on medicines for patients with private insurance will still face penalties under the Inflation Reduction Act’s drug pricing law. If drugmakers increase prices faster than the rate of...
by Jordana Choucair | Oct 6, 2022 | Life Sciences
The Biden administration’s plan to launch its own Operation Warp Speed-like initiative has reportedly stalled out. The initiative was aimed at strengthening the country’s defenses against future coronavirus strains and developing new vaccines and...
by Jordana Choucair | Oct 5, 2022 | Life Sciences
Juul Labs Inc. has started informal discussions on debtor-in-possession financing for a potential Chapter 11 bankruptcy. The Food and Drug Administration (FDA) banned Juul products on U.S. shelves in June and the company has faced a number of lawsuits. Last month, the...
by Jordana Choucair | Oct 5, 2022 | Life Sciences
The U.S. Department of Health and Human Services (HHS) Biomedical Advanced Research and Development Authority awarded Vir Biotechnology Inc. a multiyear, $55 million contract to develop drugs that combat seasonal and pandemic flu viruses. The deal includes the option...
by Jordana Choucair | Oct 4, 2022 | Life Sciences
Federal Trade Commission (FTC) Chair Lina Khan said the agency is considering all its tools, including law enforcement or market-wide rulemaking, as it scrutinizes the business practices of pharmacy benefit managers (PBMs). When asked whether existing antitrust laws...
Recent Comments